Search
Ionis Pharmaceuticals Inc
IONSAdd to Watchlist
42.800USD
-0.130-0.30%
Market hours 10/26, 13:52（ET）
7.11BMarket Cap
LossP/E TTM
Ionis Pharmaceuticals Inc (IONS) Revenue Performance
Updated: Dec 31, 2020By Business
Revenue
Proportion
Annual
Annual
Quarterly
R&D revenue under collaborative agreements
SPINRAZA royalties
Product sales, net
Licensing and other Royalty revenue
FY2020
FY2019
R&D revenue under collaborative agreements
364.56M(49.99%)
770.15M(68.60%)
SPINRAZA royalties
286.58M(39.30%)
292.99M(26.10%)
Product sales, net
70.00M(9.60%)
42.25M(3.76%)
Licensing and other Royalty revenue
8.12M(1.11%)
17.20M(1.53%)